Addendum AStock Option Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Washington
EXHIBIT 10.95 LEASE AGREEMENTLease Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
RECITALS:License Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
RECITALS:Stock Purchase Warrant • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.98 BIOMUNE SYSTEMS, INC. INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT ALL SUBSCRIBERS FOR SHARES MUST EXECUTE AN INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT. THIS INFORMATION IS NECESSARY FOR THE PURPOSE OF DETERMINING THE...Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
AGREEMENTAgreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
WITNESSETH:Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
WITNESSETH:Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.111 TERMINATION AND MUTUAL RELEASE AGREEMENT THIS TERMINATION AND MUTUAL RELEASE AGREEMENT (the "Agreement") is entered into effective as of this 1st day of September, 1996, by and between Biomune Systems, Inc., a Nevada corporation (the...Termination and Mutual Release Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.104 PURCHASE AGREEMENT This agreement, dated as of September 3, 1996, [the agreement] is made between Optim Nutrition Inc. [the Company] and ADUN & Company Ltd.[the Purchaser] in order to establish a pricing schedule for the purchase of...Purchase Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.112 FIRST AMENDMENT TO AMENDED LICENSE AGREEMENT THIS FIRST AMENDMENT TO AMENDED LICENSE AGREEMENT (the "Amendment") is entered into effective as of this 1st day of September, 1996, by and between Protein Technology, Inc., a Delaware...License Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
RECITALS:Employment and Non-Competition Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.106 Biomune Systems, Inc. NON-QUALIFIED STOCK OPTION AGREEMENT Biomune Systems, Inc., a Nevada corporation (the "Company"), hereby grants this 20th day of December, 1995, to David G. Derrick, an individual (the "Optionee"), an option to...Non-Qualified Stock Option Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
RECITALS:Registration Rights Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.99 ALLIANCE PROTOTYPE 401(K) PLAN STANDARDIZED ADOPTION AGREEMENT This standardized adoption agreement has been prepared to accommodate the needs of most employers desiring to adopt a 401(k) plan in a prototype format. It is an important...Standardized Adoption Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • New York
